April 28, 2020

Ciboney Group Limited (CBNY) for the nine months ended February 29, 2020, financial Income declined by 63% to total $16,000 from $43,000 in February 2019. For the third quarter ended February 2020, financial Income fell 99% to $3,000 from $13,000 in the corresponding quarter in 2019.

Group Operating Expenses totaled $3.11 million for the period relative to $3.96 million for the corresponding period in 2019, a 22% decline. Meanwhile for the quarter, the group operating expenses amounted to $1.03 million (2019: $1.58 million).

Operating loss, therefore, totaled $3.09 million for the nine months ended February 2020 (2019: $3.92 million). Likewise, the Company booked an operating loss for the third quarter ended February 2020 of $1.03 million (2019: $1.57 million)

The Company reported net loss after taxation of $3.09 million, this compares with the net loss of $3.92 million booked in 2019.

Net loss per share was 0.57 cents for the period compared with a loss per share of 0.72 cents in 2019. The trailing twelve months loss per a share is 0.14 cents. The number of shares used in the calculations is 546,000,000.  CBNY’s stock price closed the trading period at a price of $0.11 on April 27, 2020.

Balance Sheet at a glance:

Total Assets as at February 29, 2020 amounted to $17.60 million, up from $14.63 million as at February 28, 2019. The main reason for the increase in total asset ‘Cash and Cash Equivalents’ rose 35% to total $11.89 million compared to the $8.82 million reported in 2019.

Shareholders’ Equity amounted to $5.94 million, a decline relative to the $10.20 million reported in 2019. As such, the book per share stood at $0.011 as at as at February 29, 2020 (2019: $0.019).

Analyst Certification -The views expressed in this research report accurately reflect the personal views of Mayberry Investments Limited Research Department about those issuer (s) or securities as at the date of this report. Each research analyst (s) also certify that no part of their compensation was, is, or will be, directly or indirectly, related to the specific recommendation (s) or view (s) expressed by that research analyst in this research report.

Company Disclosure -The information contained herein has been obtained from sources believed to be reliable, however its accuracy and completeness cannot be guaranteed. You are hereby notified that any disclosure, copying, distribution or taking any action in reliance on the contents of this information is strictly prohibited and may be unlawful. Mayberry may effect transactions or have positions in securities mentioned herein. In addition, employees of Mayberry may have positions and effect transactions in the securities mentioned herein.